Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.
about
Imaging Atherosclerosis.Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targetsAnti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE studyMarkerless attenuation correction for carotid MRI surface receiver coils in combined PET/MR imaging(18)F-FDG PET and vascular inflammation: time to refine the paradigm?HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional study[18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing EndarterectomyAortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imagingImpact of bariatric surgery on carotid artery inflammation and the metabolic activity in different adipose tissues.Positron emission tomography imaging of coronary atherosclerosis.PET imaging of inflammation in atherosclerosis.PET imaging of atherosclerosis.Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation.Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT18F-FDG-PET/CT Angiography for the Diagnosis of Infective Endocarditis.Simultaneous carotid PET/MR: feasibility and improvement of magnetic resonance-based attenuation correction.Activation of the "Splenocardiac Axis" by electronic and tobacco cigarettes in otherwise healthy young adults.Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigsFeasibility of simultaneous PET/MR in diet-induced atherosclerotic minipig: a pilot study for translational imaging.Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials.PET imaging of the neurovascular interface in cerebrovascular disease.Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study.18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques.Technical considerations for quantification of (18)F-FDG uptake in carotid atherosclerosis.PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomograInfluence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis.18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis.FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.Optimizing FDG-PET/CT imaging of inflammation in atherosclerosis
P2860
Q26764836-EF489D7D-6A26-496B-96F9-B3045D95681CQ30370897-0BC26D61-D7EF-4D91-9FC1-50D8BB58C52DQ30414631-37D0A04D-5C51-4ECD-86A9-67025A074269Q30960471-FF5F90C7-DCC8-4DDD-9ACB-EBC355E564B1Q34694001-27231F9B-1A43-4BF9-B1DC-C0C5C88DCD4BQ35159845-5C4D8ADB-25C2-4ED1-97AF-5C2DE958CA3EQ35676899-0DDD5CD0-3675-4ECD-82BF-E02772ADF29AQ35777600-5955D8F9-F2FA-4462-ABE2-9C4C89BDDF0FQ35851713-DAF95745-C588-4848-9E5D-028FEABA14A8Q35929734-8E204666-FFD1-48EB-A753-610AE4FD01F2Q36152926-8927C79B-825A-49BD-84CD-97D0E823E97AQ37050963-469025D5-B7B9-4362-A2F5-4C93A41F2CFDQ38218902-2810EFA4-CF4A-405C-AFDA-E3A3A8386FEAQ38326673-C2E66FEF-E296-4CC3-8FC9-AD7D577DE87BQ38352448-38488EFD-482C-4C4D-8B1E-DDC38AE9FBF7Q38397910-0EBFF621-CA4B-46FF-B8C3-B305A7B6581FQ38605303-4C28E7C3-6721-4C1D-8F77-DBFEC3792A68Q38628616-D1B8A4AC-DC1E-4B65-AFFB-7FFB97DF3B8AQ39129362-021306A7-D747-4213-9C49-A2A128C711F1Q41033765-665C2F0F-7DC2-413B-B6CD-2E8184A2CB10Q41037847-3471B32C-6888-44DB-BF9E-E857FD8B8A69Q42013140-BCAD489D-034B-4460-9B94-D1060ECBE13EQ42814382-345E07B4-5709-4F6B-B9CD-C7DE1EA18B4DQ47158087-06FB11A9-EED7-45AA-907A-C9ADD8C2EFCCQ48031424-7D31BF3A-2354-4A17-B044-18B77C9E7290Q48032037-2892ED0F-C1F1-4547-BB2E-3688BE6A1D1FQ48533857-5446FF36-016C-44C4-BCB6-D263D69F9003Q49909152-755B23C8-811A-42DE-BD76-B149F8AC4D6EQ50697336-4F10485E-D28E-4BA0-A178-22ECC357FE58Q50957944-09D69881-9F9B-40D8-9529-0A42078A83A3Q52982204-D71F8AAD-DBF8-4C18-A362-A6A822859D53Q52983704-8E58D15B-BE44-45AE-BE39-625E3DE7C4FBQ54238129-84FDA6CD-67E1-40F2-94AD-DF9AEE051613Q57621558-B1EDECD9-88A9-49AE-9999-C6D7300F048F
P2860
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@ast
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@en
type
label
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@ast
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@en
prefLabel
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@ast
Optimizing 18F-FDG PET/CT imag ...... fasting blood glucose levels.
@en
P2093
P2860
P50
P1476
Optimizing 18F-FDG PET/CT imag ...... d fasting blood glucose levels
@en
P2093
Ahmed Tawakol
Jan Bucerius
Josef Machac
Michael E Farkouh
Zahi A Fayad
P2860
P2888
P304
P356
10.1007/S00259-013-2569-6
P577
2013-11-23T00:00:00Z